Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Formulary Drug Review: Edaravone.

Literature DB >> 29276251

Formulary Drug Review: Edaravone.

Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

Entities: Chemical

Year: 2017 PMID： 29276251 PMCID： PMC5735759 DOI： 10.1177/0018578717734877

Source DB: PubMed Journal: Hosp Pharm ISSN： 0018-5787

16 in total

1. Long-term efficacy of edaravone in patients with acute myocardial infarction.

Authors: Kenichi Tsujita; Hideki Shimomura; Koichi Kaikita; Hiroaki Kawano; Jun Hokamaki; Yasuhiro Nagayoshi; Takuro Yamashita; Masaya Fukuda; Yoshinori Nakamura; Tomohiro Sakamoto; Michihiro Yoshimura; Hisao Ogawa
Journal: Circ J Date: 2006-07 Impact factor: 2.993

2. Hyperbaric oxygen combined with intravenous edaravone for treatment of acute embolic stroke: a pilot clinical trial.

Authors: Keisuke Imai; Takahisa Mori; Hajime Izumoto; Nozomu Takabatake; Takenobu Kunieda; Masaki Watanabe
Journal: Neurol Med Chir (Tokyo) Date: 2006-08 Impact factor: 1.742

3. Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction.

Authors: Masaaki Uno; Keiko T Kitazato; Atsuhiko Suzue; Kazuhito Matsuzaki; Masahumi Harada; Hiroyuki Itabe; Shinji Nagahiro
Journal: Free Radic Biol Med Date: 2005-10-15 Impact factor: 7.376

4. Effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction.

Authors: Yoshinori Nakamura; Yoshihiro Yamada; Hideki Shimomura; Yasuhiro Nagayoshi; Kenichi Tsujita; Takuro Yamashita; Masaya Fukuda; Keisuke Ohba; Hisato Nako; Yuji Ogura; Tadasuke Chitose; Munetaka Yamaguchi; Takeshi Nagata; Hirofumi Soejima; Koichi Kaikita; Seigo Sugiyama; Hisao Ogawa
Journal: J Cardiol Date: 2009-08-20 Impact factor: 3.159

5. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).

Authors: Yukito Shinohara; Isamu Saito; Shotai Kobayashi; Shinichiro Uchiyama
Journal: Cerebrovasc Dis Date: 2009-03-26 Impact factor: 2.762

Review 6. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors: R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal: Neurology Date: 2009-10-13 Impact factor: 9.910

Review 7. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

8. Edaravone - citicoline comparative study in acute ischemic stroke (ECCS-AIS).

Authors: Manish Mitta; Deepak Goel; Krishan K Bansal; Prashant Puri
Journal: J Assoc Physicians India Date: 2012-11

9. Phase I clinical study of edaravone in healthy Chinese volunteers: safety and pharmacokinetics of single or multiple intravenous infusions.

Authors: Hao Li; Kun Xu; Yongqing Wang; Hongwen Zhang; Tianping Li; Ling Meng; Xiaojian Gong; Haibo Zhang; Ning Ou; Jinman Ruan
Journal: Drugs R D Date: 2012-06-01